Table: Noile-Immune Biotech - Q1 parent results

Noile-Immune Biotech

14/05/2024 09:00

May 14 (Reuters)- 
             Noile-Immune Biotech Inc. 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Mar 31, 2024        Mar 31, 2023     Dec 31, 2024 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             2 mln               8 mln                     
                 (-68.0 pct)                                      
  Operating     loss 339 mln        loss 269 mln                  
  Recurring     loss 339 mln        loss 493 mln                  
  Net           loss 340 mln        loss 494 mln                  
  EPS           loss 7.86 yen      loss 12.49 yen                 
  Ann Div                                NIL              NIL     
  -Q2 div                                NIL              NIL     
  -Q4 div                                NIL              NIL     
  
  NOTE - Noile-Immune Biotech Inc.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4893.T